Brian Nahed, M.D., MSc, FCNS, FAANS


Professor of Clinical Neurosurgery
Harvard Medical School
Clinical Executive Director of Strategy
Neurosurgery, Massachusetts General Hospital
Clinician Investigator, Full Professor
NSI NSurg Faculty Leadership MGPO M, Mass General Research Institute
Director, Mass General Brigham Neurosurgery Residency Program
Massachusetts General Hospital
Associate Neurosurgeon
Neurosurgery, Massachusetts General Hospital

Education

Internship Mass General hospital 2006
Neurosurgery Residency Mass General Hospital 2011
MSc 2014
MD Yale University School of Medicine 2005

Research Interests

brain mapping; brain metastases; brain neoplasms; brain tumor biomarkers; choroid plexus; circulating tumor cells; craniotomy; defensive medicine; glioblastoma; glioma; healthcare delivery; hematoma subdural; hydrocephalus; intracranial aneurysm; intracranial hemorrhages; meningioma; microfluidics; neurosurgery; neurosurgical outcomes; neurosurgical procedures; operating room efficiency

Research Narrative

Dr. Brian Nahed is Professor and Vice-Chair of Neurosurgery at the Massachusetts General Hospital / Mass General Brigham. Dr. Nahed is a brain tumor specialist and expert using intra-operative technology to ensure the best patient outcomes. He is an internationally recognized expert in brain mapping, awake surgery, language and motor mapping, subcortical stimulation, and minimally invasive procedures to treat brain tumors aggressively and safely. He has pioneered the use of intraoperative ultrasound to maximize patient outcomes and co- founded the international intraoperative ultrasound society which leads educational efforts in intraopative imaging.
 
He completed his neurosurgery residency at the Massachusetts General Hospital, and a postdoctoral fellowship with Drs. Daniel Haber and Shyamala Maheswaran in the MGH Cancer Center. Dr. Brian Nahed was recruited to the MGH Department of Neurosurgery, MGH Brain Tumor Center, and Harvard Medical School in 2011. Dr. Nahed research was the first to develop a blood test to identify and capture circulating tumor cells in the blood of patients with glioblastoma. Together with Dr. Shannon Stott, Nahed runs an NIH funded laboratory developing the first blood test for patients with brain tumors. He has published over 250 peer-reviewed articles. Dr. Brian Nahed and Dr Shannon Stott aim to develop the first blood test for brain tumors.  They are the first to identify and capture circulating tumor cells in the blood of patients with brain tumors - a landmark finding which changes our understanding of brain tumors and the blood. Dr. Nahed's research was published in Cancer Discovery and active enrolling patients in his translational clinical research study. More information about his research lab can found at the the Nahed Brain Tumor Research Lab.
 
Dr. Nahed serves as the Director of the Mass General Brigham Neurosurgery Residency Program. Nationally, he serves as the President-elect of the Congress of Neurological Surgeons and President of the CNS/AANS National Tumor Section. He co-founded and developed the CNS Leadership Institute designing leadership courses for junior, mid, and senior neurosurgeons training over 250 neurosurgeons internationally. He developed the CNS+ app, launched a chatbot, and is a leader in digital biomarkers for brain health. Dr. Nahed also serves as a lead neurotrauma consultant for the National Football League (NFL).